Materias dentro de su búsqueda.
Mostrando 2,121 - 2,140 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 1.61s Limitar resultados
  1. 2121
    “…OBJECTIVE: The aim of this study was to longitudinally evaluate and analyze the role of interleukin-22-producing CD4 positive cells (IL-22) in the pathogenesis of Hepatitis C Virus recurrence after Orthotopic Liver Transplantation (HCV-OLT). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation
  2. 2122
    “…BACKGROUND: Hepatitis C virus (HCV) has been known as a major cause of hepatocellular carcinoma (HCC) worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study
  3. 2123
    “…The purpose of this study was to assess the prevalence of anti-hepatitis C virus (HCV) antibodies (Abs) and active HCV infection in human immunodeficiency virus (HIV)-infected (HIV+) patients in Spain in 2015. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
  4. 2124
    “…Hepatitis C virus is a serious infection causing cirrhosis, liver cancer, and death. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
  5. 2125
    por Abdelwahab, Sayed F.
    Publicado 2016
    “…Hepatitis C Virus (HCV) causes chronic infection and represents a global health burden. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
  6. 2126
    “…INTRODUCTION: New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
  7. 2127
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Photo-induced drug eruption in a patient on combination simeprevir/sofosbuvir for hepatitis C
  8. 2128
    “…Like most positive-strand RNA viruses, hepatitis C virus (HCV) forms a membrane-associated replication complex consisting of replicating RNA, viral and host proteins anchored to altered cell membranes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection
  9. 2129
    “…BACKGROUND: Hepatitis C (HCV) is a deleterious virus that can be cured with new, highly effective anti-viral treatments, yet more than 185 million individuals worldwide remain HCV positive (with the vast majority un-diagnosed or untreated). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000–2013
  10. 2130
    “…Hepatitis C virus (HCV)-infected patients often suffer from liver cirrhosis, which can be complicated by renal impairment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
  11. 2131
    “…BACKGROUND: Although children comprise a small fraction of the burden of hepatitis C virus (HCV) infections, which is a major global health challenge, a significant number of them develop chronic HCV infection and are at risk of its complications. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroprevalence and Correlates of Hepatitis C Virus Infection in Secondary School Children in Enugu, Nigeria
  12. 2132
    “…Chronic hepatitis C virus (HCV) infection is a leading cause of health care utilization in the USA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Spotlight on grazoprevir–elbasvir once-daily combination and its potential in the treatment of hepatitis C
  13. 2133
    “…Here, through a novel quantitative proteogenomics approach, we demonstrated a successful identification of immunoglobulin variable heavy chain (V(H)) sequences highly enriched in pathological immune complex from clinical specimens obtained from a patient with hepatitis C virus-induced cryoglobulinemia (HCV-CG). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia
  14. 2134
    “…BACKGROUND AND RATIONALE: Most patients with chronic hepatitis C show virological response to telaprevir-based triple therapy, and achieve an end-of-treatment response (ETR). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
  15. 2135
    “…INTRODUCTION: Hepatitis C virus (HCV) infection is a major complex public health problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Knowledge, risk perception, and behavioral intention about hepatitis C, among university students
  16. 2136
    “…BACKGROUND/AIMS: The treatment strategy for hepatitis C virus (HCV) has been changing rapidly since the introduction of direct-acting antivirals such as daclatasvir (DCV) and asunaprevir (ASV). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
  17. 2137
    “…BACKGROUND: Data regarding comorbidities of hepatitis C virus infection (HCV) in the kingdom of Saudi Arabia (KSA) are lacking. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia
  18. 2138
    “…Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are the main inducers of a cross-neutralizing antibody response which plays an important role in the early phase of viral infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex
  19. 2139
    “…Quercetin is a natural flavonoid, which has been shown to have anti hepatitis C virus (HCV) properties. However, the exact mechanisms whereby quercetin impacts the HCV life cycle are not fully understood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets
  20. 2140
    “…The high rate of hepatitis C virus (HCV) infection among transfusion related risk groups such as patients with inherited bleeding disorders highlighting the investigation on prevalent subtypes and their epidemic history among this group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran
Herramientas de búsqueda: RSS